Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation "AREST"

Recruiting

Phase 3 Results N/A

Summary of Purpose

The purpose of this study is to evaluate if Apixaban will decrease the complication of having another stroke for people who have atrial fibrillation if initiated earlier than standard of care.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 November 2017.

1 Apr 2015 29 Oct 2014 1 Dec 2018 1 Dec 2018 1 Nov 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

See All